Article By:
The Dividend Guy
Thursday, January 2, 2020 9:54 AM EST
Three strong dividend-paying companies that didn’t do so well recently. Here’s your chance to grab some shares at a good price.
AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
How much debt does $ABBV have?
AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
$ABBV certainly sounds like a great buy.
AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).